marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-31-2024
Syros Pharmaceuticals Cash Flow 2011-2024 | SYRS
Annual Cash Flow Syros Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-110 M | -123 M | -99.5 M | -57.4 M | -60.3 M | -40.3 M | -44.7 M | -40.5 M | -23 M | - | - | - | - |
Depreciation & Amortization |
2.25 M | 2.71 M | 2.76 M | 2.77 M | 2.52 M | 1.6 M | 1.53 M | 1.27 M | 602 K | 258 K | - | - | - |
Accounts Payables |
11.5 M | 6.41 M | 3.69 M | 3.6 M | 5.85 M | 3.31 M | 2.28 M | 2.42 M | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | 867 K | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Syros Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -31.1 M | - | - | - | -36.9 M | - | -92 M | -56.2 M | -30 M | - | -76.6 M | -48.4 M | -22 M | - | -27.4 M | -12.2 M | 246 K | - | -49.6 M | -38.4 M | -20.3 M | - | -26.5 M | -16.5 M | -2.4 M | - | -34.2 M | -24.6 M | -12.8 M | - | -30.9 M | -21.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | 334 K | - | - | - | 638 K | - | 2 M | 1.34 M | 681 K | - | 2.05 M | 1.35 M | 666 K | - | 2.07 M | 1.37 M | 678 K | - | 1.69 M | 1.1 M | 517 K | - | 1.17 M | 764 K | 388 K | - | 1.14 M | 746 K | 365 K | - | 935 K | 620 K | 304 K | - | 373 K | 184 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
9.65 M | 7.47 M | 11.3 M | 11.5 M | 2.86 M | 6.69 M | 2.8 M | 6.41 M | 13 M | 6.12 M | 2.84 M | 3.69 M | 4.11 M | 3.67 M | 3.66 M | 3.6 M | 3.6 M | 3.6 M | 3.6 M | 5.85 M | 5.85 M | 5.85 M | 5.85 M | 3.31 M | 3.31 M | 3.31 M | 3.31 M | 2.28 M | 2.28 M | 2.28 M | 2.28 M | 2.42 M | 2.42 M | 2.42 M | 2.42 M | 5.04 M | 5.04 M | 5.04 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7 K | 7 K | 7 K | 7 K | 20 M | 20 M | 20 M | 20 M | - | - | - | - | - | - | - | 551 K | 867 K | 867 K | 867 K | 867 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency